Case report reveals radiation recall dermatitis triggered by adjuvant capecitabine in a triple-negative breast cancer patient, highlighting capecitabine as a potential cause of recall reactions.
Radiation recall dermatitis (RRD) is an acute inflammation of the skin, i.e., produced by drugs, most commonly chemotherapeutic treatments, in an area of the body that has been treated with radiation in the past. This case report describes the clinical experience of a triple-negative breast cancer patient who developed RRD after postoperative radiotherapy following adjuvant capecitabine treatment. The timing of chemotherapy after radiation therapy and the improvement in radiation dermatitis following capecitabine avoidance suggest that the reaction was a true radiation recall phenomenon.
No takes yet. Share an insight, caveat, or question.
Talukdar et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: